Subjects with acute or chronic inflammatory disease, those that had undergone steroid treatment in the last 3 months or had recently taken part in a weight loss intervention/surgery were excluded
352(n)] has reflected the principle that disclosing material facts that include the consequences of using the drug to which labeling or advertising relates is key to ensuring that such communications are not misleading)
When prescribed by a healthcare provider, these medications may be used as part of a personalized weight management plan
This applies to both brand-name and compounded formulations, as well as the telehealth consultation fees
Research studies have shown that these GLP-1 medications are superior to other long-term FDA-approved anti-obesity medications like orlistat (Xenical, Alli), phentermine-topiramate (Qsymia), and bupropion-naltrexone (Contrave), leading to almost 20% loss of initial body weight
Compared to control groups, patients prescribed GLP-1 medications exhibited a significant decrease in the likelihood of subsequent anxiety and depression